MTOR and acute graft versus host disease: To conclude, circulating T cells as well as CD3− cells derived from allotransplant recipients with previous acute GVHD showed generally stronger PMA phosphoresponses for AKT (Thr308), mTOR (Ser2448) and STAT3 (Ser727), than T cells from patients without previous GVHD.